A Phase II Trial of Dovitinib in Bacillus Calmette-Guerin(BCG) Refractory Urothelial Carcinoma Patients With Tumor Fibroblast Growth Factor Receptor 3(FGFR3) Mutations or Over-expression: Hoosier Cancer Research Network GU12-157
NM Hahn, TJ Bivalacqua, A Ross, GJ Netto, JC Park, TA Masterson, MO Koch, R Bihrle, R Foster, TA Gardner, L Cheng, DR Jones, K McElyea, G Sandusky, Z Liu, SA Turner, GJ Tsongalis, ER Plimack, RE Greenberg, DM Geynisman
NM Hahn, TJ Bivalacqua, AE Ross, GJ Netto, A Baras, JC Park, C Chapman, TA Masterson, MO Koch, R Bihrle, RS Foster, TA Gardner, L Cheng, DR Jones, K McElyea, GE Sandusky, T Breen, Z Liu, C Albany, ML Moore, RL Loman, A Reed, SA Turner, FB De Abreu, T Gallagher, GJ Tsongalis, ER Plimack, RE Greenberg, DM Geynisman
Trial Locations
All sites in which the trial GU12-157 being conducted in.
